HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.

Abstract
Insulin-like growth factor binding protein 4-1 (IGFBP4-1), a new long noncoding RNA (lncRNA), has been reported to contribute to tumorigenesis and has been suggested to be a poor prognostic marker in human lung cancer. However, there still lacks basic studies that investigated the biological role of IGFBP4-1 in bladder urothelial carcinoma to date. In this study, we investigated the relationship between IGFBP4-1 expression and prognosis in patients with bladder cancer. Cell proliferation, cell cycle and cell apoptosis assays were performed to assess IGFBP4-1 function by up-regulating or down-regulating IGFBP4-1 in bladder cancer cells. A xenograft mice model was used to validate the in vitro results. Blockade of Janus kinase-signal transducer and activator of transcription pathway (JAK/STAT) was used to evaluate JAK/STAT signaling activity. The results showed that IGFBP4-1 was overexpressed in bladder cancer tissues compared with that in normal bladder tissues, and its expression level was positively correlated with poor prognosis in bladder cancer patients. Overexpression of IGFBP4-1 markedly promoted cell proliferation and cell cycle progression, and inhibited cell apoptosis, while knockdown of IGFBP4-1 notably suppressed the proliferation, promoted cell apoptosis, and induced cell cycle arrest at the G0/G1 phase. Mechanistically, we revealed that IGFBP4-1 promotes the activation of the JAK/STAT pathway in bladder cancer cells. Moreover, the JAK/STAT inhibitor dramatically blocked the tumor-promoting activity of IGFBP4-1. Tumor growth in vivo was also suppressed by knocking down of IGFBP4-1. In conclusion, IGFBP4-1 promoted bladder cancer progression by activating the JAK/STAT signaling pathway. These findings suggest that IGFBP4-1 exhibits an oncogenic role in the development of human bladder cancer.
AuthorsChunjing Li, Yu Cao, Li Zhang, Jierong Li, Huayan Wu, Fengsheng Ling, Jintao Zheng, Jianfeng Wang, Bowei Li, Jun He, Xumin Xie, Zhilin Li, Yiping Chen, Xuemei He, Mingjuan Guo, Huiling Wei, Jing Ye, Yun Guo, Shilin Zhang, Liang Liu, Guoqing Liu, Chunxiao Liu
JournalInternational journal of biological sciences (Int J Biol Sci) Vol. 16 Issue 13 Pg. 2271-2282 ( 2020) ISSN: 1449-2288 [Electronic] Australia
PMID32760196 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Retracted Publication)
Copyright© The author(s).
Chemical References
  • IGFBP4 protein, human
  • Insulin-Like Growth Factor Binding Protein 4
  • RNA, Long Noncoding
  • STAT Transcription Factors
  • Janus Kinases
Topics
  • Animals
  • Apoptosis
  • Carcinoma (genetics, metabolism)
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Proliferation
  • Databases, Genetic
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Insulin-Like Growth Factor Binding Protein 4 (genetics, metabolism)
  • Janus Kinases (genetics, metabolism)
  • Male
  • Mice
  • Mice, Nude
  • Middle Aged
  • Neoplasms, Experimental
  • RNA, Long Noncoding
  • STAT Transcription Factors (genetics, metabolism)
  • Up-Regulation
  • Urinary Bladder Neoplasms (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: